Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06801717 · ClinicalTrials.gov registry record · NA
Rosacea Radiofrequency Microneedling
A NA study of Rosacea, Papulopustular and Rosacea, Erythematotelangiectatic, sponsored by University of Miami.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT06801717 is a NA study of Rosacea, Papulopustular and Rosacea, Erythematotelangiectatic that is actively recruiting participants, run by University of Miami. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06801717, a NA study of Rosacea, Papulopustular and Rosacea, Erythematotelangiectatic, is actively recruiting participants, sponsored by University of Miami.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
There are 3 main objectives of this proposal as follows: (1) to assess the efficacy of radiofrequency microneedling in the treatment of erythematotelangiectatic and or papulopustular rosacea, (2) to determine the potential for combination treatment of radiofrequency microneedling with the 532 nm KTP laser, and (3) identify potential novel therapeutic strategies for the treatment of rosacea.
Conditions Studied
Interventions
- DEVICE KTP Laser Therapy
- DEVICE Radiofrequency microneedling
Study Locations (1)
Florida
- University of Miami Dermatology Miami Beach Clinic - Miami Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-11-01 |
| Est. Completion | 2026-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06801717
The ClinicalTrials.gov registry entry for NCT06801717 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Rosacea, Papulopustular appearing as the primary indexed condition, and to 2 interventions - of which KTP Laser Therapy is the first listed.
NCT06801717 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT06801717 about?
NCT06801717 is a clinical study titled "Rosacea Radiofrequency Microneedling". There are 3 main objectives of this proposal as follows: (1) to assess the efficacy of radiofrequency microneedling in the treatment of erythematotelangiectatic and or papulopustular rosacea, (2) to determine the potential for combination treatment of radiofrequency microneedling with the 532 nm KTP...
What is the current status of trial NCT06801717?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2024-11-01. Estimated completion is 2026-04-01.
What conditions does trial NCT06801717 study?
This clinical trial studies the following conditions: Rosacea, Papulopustular, Rosacea, Erythematotelangiectatic.
What interventions are being tested in trial NCT06801717?
The interventions under investigation include: KTP Laser Therapy (DEVICE), Radiofrequency microneedling (DEVICE).
Who is sponsoring clinical trial NCT06801717?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06801717 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.